Abiopharma

🔍 King David Lee (Executive)

Company: Primoris Services Corp (PRIM)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 21,774 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,242.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 8,569 shares of Common Stock at $143.04 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 34,673.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 21,774 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of PRIM common stock or the cash value thereof on the date of settlement, in the Company's discretion. On April 1, 2026, the restricted stock units vested and were settled for an equal number of shares of PRIM common stock.
• F2: Withholding of common stock to satisfy reporting person's tax obligation upon the settlement of vested restricted stock units.